Skip to main content
Monday, November 9, 2026Nov 9

First pill for fecal transplants wins FDA approval

This photo provided by Seres Therapeutics shows manufacturing equipment for oral microbiome therapeutic capsules in the company's Cambridge, Mass., facility in May 2022.(Genevieve de Manio/Seres Therapeutics via AP)
This photo provided by Seres Therapeutics shows manufacturing equipment for oral microbiome therapeutic capsules in the company's Cambridge, Mass., facility in May 2022.(Genevieve de Manio/Seres Therapeutics via AP) This photo provided by Seres Therapeutics shows manufacturing equipment for oral microbiome therapeutic capsules in the company's Cambridge, Mass., facility in May 2022.(Genevieve de Manio/Seres Therapeutics via AP)

WASHINGTON (AP) — U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants.

The new treatment from Seres Therapeutics provides a simpler, rigorously tested version of stool-based procedures that some medical specialists have used for more than a decade to help hard-to-treat patients.

The Food and Drug Administration cleared the capsules for adults who face risks of repeat infections with Clostridium difficile, a bacteria that can cause severe nausea, cramping and diarrhea.

C. diff is particularly dangerous when it reoccurs, leading to between 15,000 and 30,000 deaths per year. It can be killed with antibiotics but they also destroy good bacteria that live in the gut, leaving it more susceptible to future infections. The new capsules are approved for patients who have already received antibiotic treatment.

More than 10 years ago, some doctors began reporting success with fecal transplants — using stool from a healthy donor — to restore the gut’s healthy balance and prevent reinfections.